| Application no. and date | 16190004.8 (espacenet) (Federated) (European Patent Register), 20100715 | | Patent/reg. no. and date | DK/EP 3178490, 20220420 | | Publication date | 20170614 | | Priority no. and date | US 225805 P, 20090715, US 294426 P, 20100112 | | EP pub. no. and date |
EP 3178490 20170614 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals S.A., Rue de l'Institut, 89
1330 Rixensart, BE | | Applicant ref. no. | V443474DK00 | | Inventor | SWANSON, Kurt, c/o Novartis Vaccines and Diagnostics, Inc.
IP Services M/S X-100B
P.O. Box 8097
Emeryville, CA 94662-8097, US,
DORMITZER, Philip, R., c/o Novartis Vaccines and Diagnostics, Inc.
IP Services M/S X-100B
P.O. Box 8097
Emeryville, CA 94662-8097, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/155 (2006.01) , C07K 14/135 (2006.01) , C07K 16/10 (2006.01) | | Title | RSV F-proteinsammensætninger og fremgangsmåder til fremstilling af disse | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
